Gene mutation

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
C Cardiology (ATC C) 1
Mechanism of action (INN-stem analysis)
ARB 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Fundacion Para La Investigacion Biomedica Del Hospital Universitario Puerta De Hierro Majadahonda Academic
    CANDESARTAN CILEXETIL
    2023-507029-40-00 2 countries 2022 n=430
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Fundacion Para La Investigacion Biomedica Del Hospital Universitario Puerta De Hierro Majadahonda Academic 1 Phase III 1
New trials by year
2022
1
← All indication landscapes